Publications

5532 Results

Development of a predictive model for aggressive lymphoma. The International NHL prognostic factors project.

Authors
N Shipp;D Harrington;J Anderson;J Armitage;G Bonadonna;G Brittinger;F Cabanillas;G Canellas;R Coiffier;J Connors;R Cowan;C Crowther;M Engelhard;R Fisher;C Gisselbrecht;E Horning;E Lepage;A Lister;J Meerwaldt;E Montserrat;N Nissen;M Oken;B Peterson;C Tondini;W Valasquez;B Yeap
Journal / Conference
ASCO 11:319(#1084)
Year
1992
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508

Expression of myeloid antigens in adult acute lymphoblastic leukemia: The Southwest Oncology Group experience.

Authors
DH Boldt;K Kopecky;D Head;G Gehly;J Radich;FR Appelbaum
Journal / Conference
ASCO 11:263(#863)
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8417/19

A comparison of leuprolide and flutamide vs leuprolide alone in newly diagnosed stage D2 prostate cancer: Prognostic and therapeutic importance of the minimal disease subset.

Authors
M Eisenberger;ED Crawford;D McLeod;R Benson;A Dorr;B Blumenstein
Journal / Conference
ASCO 11:201(#619)
Year
1992
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Prognostic factors in patients with advanced renal cell carcinoma (RCC): The Southwest Oncology Group experience.

Authors
ME Marshall;P Goodman;P Kuebler;R Flanigan;ED Crawford
Journal / Conference
ASCO 11:206(#638)
Year
1992
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8504, SWOG-8617, SWOG-8707, SWOG-8716, SWOG-8728, SWOG-8802

Maintenance BCG immunotherapy of superficial bladder cancer: A randomized prospective Southwest Oncology Group study.

Authors
DL Lamm;ED Crawford;B Blumenstein;MF Sarosdy;HB Grossman;RD Bohl;B Lowe;TD Moon;WL Weems;TM Beck;J Montie;JA Smith;J Crissman;CA Coltman Jr
Journal / Conference
ASCO 11:203(#627)
Year
1992
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

A phase III comparison of CHOP vs m-BACOD vs ProMACE-CytaBOM vs MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphoma: Preliminary results of SWOG-8516 (Intergroup 0067).

Authors
RI Fisher;E Gaynor;S Dahlberg;EM Mize;M Oken
Journal / Conference
ASCO 11:315(#1067), oral, plenary session (Proceedings of ASCO, Vol. 11, March 1992, p.315)
Year
1992
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

The effect of peri-operative blood transfusion on survival in head and neck cancer.

Authors
DE Schuller;C Scott;K Wilson;R Freer;M Al-Sarraf;J Jacobs;R Ahmad;R Casiano;G Laramore
Journal / Conference
Third International Conference on Head and Neck Cancer 103:(#211)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Chemotherapy as predictor of compliance.

Authors
JR Jacobs;R Casiano;DE Schuller;TF Pajak;GE Laramore;M Al-Sarraf
Journal / Conference
Third International Conference on Head and Neck Cancer 62:(#49)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

An association between DNA diploid tumors and margin negative surgical resections: Implications for adjuvant trials in patients with advanced, resectable squamous cell carcinomas of the head and neck (SCCHN).

Authors
JF Ensley;H Pietraszkiewicz;M Del Alonso;Z Maciorowski;F deBraud
Journal / Conference
ASCO 11:242(#779)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

The Intergroup study of fluorouracil (5-FU) plus levamisole (LEV) and levamisole alone as adjuvant therapy for stage C colon cancer. A final report.

Authors
C Moertel;T Fleming;J Macdonald;D Haller;J Laurie
Journal / Conference
ASCO 11:161(#457)
Year
1992
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)